Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Small Cell Lung Carcinoma 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Tobacco Use Disorder 1

Interventions

Counseling 4Early Intervention, Educational 3Tobacco Use Cessation Devices 2Nicotine Replacement Therapy 2Nicotine 2Bupropion 2phenethyl isothiocyanate 1phenanthrene tetraol 1phenanthrene 1Zinc Oxide 1X-Rays 1Varenicline 1Sulindac 1Spectroscopy, Fourier Transform Infrared 1Risk Factors 1Psychiatric Rehabilitation 1Polymerase Chain Reaction 1Methods 1Memantine 1Immunohistochemistry 1Gene Expression Profiling 1Focus Groups 1Fertility 1Endoscopic Mucosal Resection 1Drug Therapy 1Cognitive Behavioral Therapy 1Calcitriol 1Behavior Therapy 1Aspirin 14-((methylnitrosoamino)-1-(3-pyridyl)but-1-yl)beta-omega-glucosiduronic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Tobacco Use Disorder × phenethyl isothiocyanate × Thoracic × Clear all
NCT00691132 2017-05-12

Phenethyl Isothiocyanate in Preventing Lung Cancer in Smokers

University of Minnesota

Phase 2 Completed
107 enrolled 18 charts
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Tobacco Use Disorder, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡